ISDA

Deposition Date 2014-06-24

Release Date 2014-10-15

Last Version Date 2023-12-27

Entry Detail

PDB ID:

4TUH

Keywords:

APOPTOSIS

Title:

Bcl-xL in complex with inhibitor (Compound 10)

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.80 Å

R-Value Free:

0.20

R-Value Work:

0.17

R-Value Observed:

0.17

Space Group:

P 1 21 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Bcl-2-like protein 1
Gene (Uniprot):BCL2L1
Chain IDs:A, B, C, D, E, F, G, H
Chain Length:158
Number of Molecules:8
Biological Source:Homo sapiens

UniProt ID:Q07817 Pfam ID:PF02180, PF00452

Ligand Molecules

38H

ACT

EDO

Primary Citation

Structure-Guided Rescaffolding of Selective Antagonists of BCL-XL.

Koehler, M.F, Bergeron, P, Choo, E.F, Lau, K, Ndubaku, C, Dudley, D, Gibbons, P, Sleebs, B.E, Rye, C.S, Nikolakopoulos, G, Bui, C, Kulasegaram, S, Kersten, W.J, Smith, B.J, Czabotar, P.E, Colman, P.M, Huang, D.C, Baell, J.B, Watson, K.G, Hasvold, L, Tao, Z.F, Wang, L, Souers, A.J, Elmore, S.W, Flygare, J.A, Fairbrother, W.J, Lessene, G.Show

Acs Med.Chem.Lett. 5 662 667 (2014)

PMID: 24944740 DOI: 10.1021/ml500030p

Abstact

Because of the promise of BCL-2 antagonists in combating chronic lymphocytic leukemia (CLL) and non-Hodgkin's lymphoma (NHL), interest in additional selective antagonists of antiapoptotic proteins has grown. Beginning with a series of selective, potent BCL-XL antagonists containing an undesirable hydrazone functionality, in silico design and X-ray crystallography were utilized to develop alternative scaffolds that retained the selectivity and potency of the starting compounds.

Legend

Protein

Chemical

Disease

Primary Citation of related structures